XM does not provide services to residents of the United States of America.

New York Times business news - Aug 13



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>PRESS DIGEST- New York Times business news - Aug 13</title></head><body>

Aug 13 (Reuters) -The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.


- Elon Musk’s live conversation with former president Donald Trump on X got off to a glitchy start on Monday in a setback for the social media service as Musk pushes to regain its dominance as an online epicenter of political discourse.


- Uber UBER.N is seeking to place a measure on Nevada’s ballot that would drastically limit the amount of money lawyers could collect when they brought successful lawsuits.


- The Psychopharmacology journal retracted three papers on MDMA-assisted therapy due to unethical conduct at one of the research sites. Several of the papers’ authors are affiliated with Lykos Therapeutics, whose application for MDMA-assisted therapy to treat post-traumatic stress disorder was rejected last week by the Food and Drug Administration.


- A group of senior Biden administration officials is traveling to Shanghai this week for high-level meetings and is expected to discuss ways to maintain economic and financial stability, capital markets and efforts to curb the flow of fentanyl into the United States.


- Democrats will hear from three presidents - Joe Biden, Barack Obama and Bill Clinton - at their convention next week in Chicago, where they will gather to recognize Vice President Kamala Harris as their presidential nominee and celebrate an unexpected campaign that has turned the race on its head.


- The New York Times editorial board will no longer make endorsements in New York elections, including in races for governor and mayor of New York City, the Times’s Opinion editor said, as a growing number of news outlets are moving away from political endorsements.



Compiled by Bengaluru newsroom; Editing by Sumana Nandy

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.